Breakthroughs in Generalized Myasthenia Gravis
February 26, 2025
Event Details
Ready to level up your generalized myasthenia gravis (gMG) management skills? This CME webinar offers neurologists a deep dive into the latest advancements in gMG care. Explore how a better understanding of the disease burden can drive smarter clinical decisions and discover how neonatal Fc receptor inhibitors are reshaping long-term treatment strategies. With insights on the pathophysiology and exploration of real-world evidence, you’ll gain the necessary tools to personalize care and achieve better, lasting outcomes for your patients. Following the webinar, join us for the AfterShow Q&A: a live breakout session! Connect directly with faculty, engage in discussions, and ask individualized questions in a collaborative and dynamic environment.
*Wednesday 2/26*
Start: 7:00 PM ET
End: 8:15 PM ET
Agenda
Introduction
Understanding Clinical Presentation and Disease Burden
Hans D. Katzberg, MD
Patient Journey: Part 1 – Assessing Disease Burden and Severity
Nicholas Silvestri, MD, with panel discussion
Understanding Disease Pathophysiology and Limitations of Conventional Therapies
Nicholas Silvestri, MD
Patient Journey: Part 2 – Managing Adverse Effects and Re-evaluating Treatment Based on Pathophysiology
Nicholas Silvestri, MD, with panel discussion
Targeted Treatment Approaches: Current and Emerging FcRn Antagonists
Vera Bril, MD
Patient Journey: Part 3 – Integrating FcRn Inhibitors Into Short- and Long-Term Management Plans
Nicholas Silvestri, MD, with panel discussion
Conclusion
After-Show Question & Answer
Join us for the AfterShow Q&A—a live breakout session where you will connect directly with faculty, engage in discussions, and ask your questions. Cameras and microphones are encouraged!